AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. AMKR
  4. [Form 4] Amkor Technology Inc Insider Trading Activity

[Form 4] Amkor Technology Inc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Alafi Capital Company, LLC and its managing member Christopher D. Alafi filed Amendment No. 1 to Schedule 13G for CalciMedica, Inc. (CALC).

  • Event date: 22 Jul 2025; filing date: 5 Aug 2025.
  • Beneficial ownership: 1,583,153 common shares.
  • Represents 11.3 % of the 13,971,990 shares outstanding (per CALC 10-Q dated 14 May 2025).
  • All shares held by Alafi Capital; Mr. Alafi, as sole managing member, has identical sole voting & dispositive power.
  • No shared power; stake reported under Rule 13d-1(c) as a passive investment.

The certification states the securities were not acquired to influence control of the issuer, and no group or subsidiary relationships apply. No changes to company operations, financials or additional transactions are disclosed.

Key takeaway: Alafi remains a double-digit passive holder, offering potential proxy influence but signalling no activist intent.

Alafi Capital Company, LLC e il suo membro gestore Christopher D. Alafi hanno presentato l'Emendamento n. 1 al Modulo 13G per CalciMedica, Inc. (CALC).

  • Data dell'evento: 22 luglio 2025; data di deposito: 5 agosto 2025.
  • Partecipazione detenuta: 1.583.153 azioni ordinarie.
  • Rappresenta il 11,3% delle 13.971.990 azioni in circolazione (secondo il 10-Q di CALC del 14 maggio 2025).
  • Tutte le azioni sono detenute da Alafi Capital; il Sig. Alafi, in qualit脿 di unico membro gestore, detiene il pieno potere di voto e decisionale.
  • Nessun potere condiviso; la partecipazione 猫 segnalata ai sensi della Regola 13d-1(c) come investimento passivo.

La certificazione afferma che i titoli non sono stati acquisiti per influenzare il controllo dell'emittente e non si applicano relazioni di gruppo o di societ脿 controllate. Non sono state comunicate modifiche alle operazioni aziendali, ai dati finanziari o altre transazioni.

Punto chiave: Alafi rimane un detentore passivo a doppia cifra, offrendo potenziale influenza tramite delega ma senza indicare intenti attivisti.

Alafi Capital Company, LLC y su miembro administrador Christopher D. Alafi presentaron la Enmienda No. 1 al Anexo 13G para CalciMedica, Inc. (CALC).

  • Fecha del evento: 22 de julio de 2025; fecha de presentaci贸n: 5 de agosto de 2025.
  • Participaci贸n beneficiaria: 1,583,153 acciones comunes.
  • Representa el 11.3% de las 13,971,990 acciones en circulaci贸n (seg煤n el 10-Q de CALC del 14 de mayo de 2025).
  • Todas las acciones est谩n en manos de Alafi Capital; el Sr. Alafi, como 煤nico miembro administrador, tiene el poder exclusivo de voto y disposici贸n.
  • No hay poder compartido; la participaci贸n se reporta bajo la Regla 13d-1(c) como inversi贸n pasiva.

La certificaci贸n indica que los valores no fueron adquiridos para influir en el control del emisor y no aplican relaciones de grupo o subsidiarias. No se divulgan cambios en las operaciones, finanzas o transacciones adicionales.

Punto clave: Alafi sigue siendo un accionista pasivo con doble d铆gito, ofreciendo potencial influencia por poder pero sin mostrar intenci贸n activista.

Alafi Capital Company, LLC鞕� 攴� 甏�毽� 氅る矂 Christopher D. Alafi臧赌 CalciMedica, Inc. (CALC)鞐� 雽�頃� 13G 鞀れ紑欷� 靾橃爼鞎� 1順鸽ゼ 鞝滌稖頄堨姷雼堧嫟.

  • 靷贝 雮犾: 2025雲� 7鞗� 22鞚�; 鞝滌稖 雮犾: 2025雲� 8鞗� 5鞚�.
  • 鞁れ 靻岇湢 欤检嫕: 1,583,153 氤错喌欤�.
  • 鞝勳泊 氚滍枆 欤检嫕 13,971,990欤检潣 11.3%鞐� 頃措嫻頃� (2025雲� 5鞗� 14鞚检瀽 CALC 10-Q 旮办).
  • 氇摖 欤检嫕鞚� Alafi Capital鞚� 氤挫湢; Alafi 鞌姅 雼弲 甏�毽� 氅る矂搿滌劀 雼弲 鞚橁舶甓� 氚� 觳橂秳 甓岉暅鞚� 臧赌歆�.
  • 瓿奠湢 甓岉暅 鞐嗢潓; 鞚� 歆�攵勳潃 Rule 13d-1(c)鞐� 霐半澕 靾橂彊鞝� 韴瀽搿� 鞁犼碃霅�.

鞚胳靹滊姅 頃措嫻 歃濌秾鞚� 氚滍枆靷� 歆�氚瓣秾鞐� 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲媹氅�, 攴鸽９ 霕愲姅 鞛愴殞靷� 甏�瓿勱岸� 鞐嗢潓鞚� 氇呾嫓頃╇媹雼�. 須岇偓 鞖挫榿, 鞛 霕愲姅 於旉岸� 瓯半灅鞐� 雽�頃� 氤�瓴� 靷暛鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

頃奠嫭 鞖旍爯: Alafi電� 霊� 鞛愲靾橃潣 靾橂彊鞝� 氤挫湢鞛愲 雮晞 鞛堨溂氅�, 鞛犾灛鞝� 雽�毽� 鞓來枼霠レ潉 鞝滉车頃橃毵� 頄夒彊欤检潣 鞚橂弰電� 鞐嗢潓鞚� 鞁滌偓頃╇媹雼�.

Alafi Capital Company, LLC et son membre gestionnaire Christopher D. Alafi ont d茅pos茅 l'Amendement n掳1 au Schedule 13G pour CalciMedica, Inc. (CALC).

  • Date de l'茅v茅nement : 22 juillet 2025 ; date de d茅p么t : 5 ao没t 2025.
  • Participation b茅n茅ficiaire : 1 583 153 actions ordinaires.
  • 搁别辫谤茅蝉别苍迟别 11,3 % des 13 971 990 actions en circulation (selon le 10-Q de CALC en date du 14 mai 2025).
  • Toutes les actions sont d茅tenues par Alafi Capital ; M. Alafi, en tant que membre gestionnaire unique, d茅tient le pouvoir exclusif de vote et de disposition.
  • Pas de pouvoir partag茅 ; la participation est d茅clar茅e selon la r猫gle 13d-1(c) comme un investissement passif.

La certification pr茅cise que les titres n'ont pas 茅t茅 acquis dans le but d'influencer le contr么le de l'茅metteur et qu'aucune relation de groupe ou filiale ne s'applique. Aucun changement dans les op茅rations, les finances ou des transactions suppl茅mentaires n'est divulgu茅.

Point cl茅 : Alafi reste un actionnaire passif 脿 deux chiffres, offrant une influence potentielle par procuration mais sans intention activiste.

Alafi Capital Company, LLC und sein gesch盲ftsf眉hrendes Mitglied Christopher D. Alafi haben die 脛nderung Nr. 1 zum Schedule 13G f眉r CalciMedica, Inc. (CALC) eingereicht.

  • Veranstaltungsdatum: 22. Juli 2025; Einreichungsdatum: 5. August 2025.
  • Beg眉nstigter Eigentum: 1.583.153 Stammaktien.
  • Entspricht 11,3 % von 13.971.990 ausstehenden Aktien (laut CALC 10-Q vom 14. Mai 2025).
  • Alle Aktien werden von Alafi Capital gehalten; Herr Alafi besitzt als alleiniger gesch盲ftsf眉hrender Gesellschafter alleinige Stimm- und Verf眉gungsgewalt.
  • Keine geteilte Macht; Beteiligung wird gem盲脽 Regel 13d-1(c) als passive Investition gemeldet.

Die Bescheinigung besagt, dass die Wertpapiere nicht zum Zweck der Kontrolle des Emittenten erworben wurden und keine Gruppen- oder Tochtergesellschaftsbeziehungen vorliegen. Es werden keine 脛nderungen an der Gesch盲ftst盲tigkeit, den Finanzen oder weiteren Transaktionen offengelegt.

Wichtigste Erkenntnis: Alafi bleibt ein passiver Anteilseigner mit zweistelligem Anteil, der potenziellen Einfluss 眉ber Stimmrechtsvertretung bietet, aber keine aktivistischen Absichten signalisiert.

Positive
  • None.
Negative
  • None.

Insights

TL;DR (25 words) Passive filing shows Alafi retains 11.3 % of CALC; material ownership visibility, but no new capital, guidance, or activist signal鈥攏eutral impact.

The amendment confirms an unchanged, sizable stake rather than a new purchase or disposal. While a double-digit holder can sway shareholder votes, the 13G classification and explicit certification rule out control motives. Without transaction details or operational commentary, the filing does not alter near-term valuation models. Visibility of a committed investor may improve sentiment, yet lacks earnings or cash-flow implications. Overall effect on CALC鈥檚 risk-reward profile is neutral.

TL;DR (24 words) Alafi鈥檚 11.3 % passive stake adds governance weight but, absent activist intent, poses minimal immediate strategic pressure on CalciMedica鈥檚 board.

An 11 % holder surpasses common 5 % reporting thresholds, making Alafi a key constituency in future proxy matters. However, the Schedule 13G (rather than 13D) and certification against control objectives indicate a hands-off posture. The filing lists sole, not shared, voting power, simplifying ownership structure and reducing coordination risks. Unless Alafi re-files on Form 13D or increases ownership materially, governance impact remains modest.

Alafi Capital Company, LLC e il suo membro gestore Christopher D. Alafi hanno presentato l'Emendamento n. 1 al Modulo 13G per CalciMedica, Inc. (CALC).

  • Data dell'evento: 22 luglio 2025; data di deposito: 5 agosto 2025.
  • Partecipazione detenuta: 1.583.153 azioni ordinarie.
  • Rappresenta il 11,3% delle 13.971.990 azioni in circolazione (secondo il 10-Q di CALC del 14 maggio 2025).
  • Tutte le azioni sono detenute da Alafi Capital; il Sig. Alafi, in qualit脿 di unico membro gestore, detiene il pieno potere di voto e decisionale.
  • Nessun potere condiviso; la partecipazione 猫 segnalata ai sensi della Regola 13d-1(c) come investimento passivo.

La certificazione afferma che i titoli non sono stati acquisiti per influenzare il controllo dell'emittente e non si applicano relazioni di gruppo o di societ脿 controllate. Non sono state comunicate modifiche alle operazioni aziendali, ai dati finanziari o altre transazioni.

Punto chiave: Alafi rimane un detentore passivo a doppia cifra, offrendo potenziale influenza tramite delega ma senza indicare intenti attivisti.

Alafi Capital Company, LLC y su miembro administrador Christopher D. Alafi presentaron la Enmienda No. 1 al Anexo 13G para CalciMedica, Inc. (CALC).

  • Fecha del evento: 22 de julio de 2025; fecha de presentaci贸n: 5 de agosto de 2025.
  • Participaci贸n beneficiaria: 1,583,153 acciones comunes.
  • Representa el 11.3% de las 13,971,990 acciones en circulaci贸n (seg煤n el 10-Q de CALC del 14 de mayo de 2025).
  • Todas las acciones est谩n en manos de Alafi Capital; el Sr. Alafi, como 煤nico miembro administrador, tiene el poder exclusivo de voto y disposici贸n.
  • No hay poder compartido; la participaci贸n se reporta bajo la Regla 13d-1(c) como inversi贸n pasiva.

La certificaci贸n indica que los valores no fueron adquiridos para influir en el control del emisor y no aplican relaciones de grupo o subsidiarias. No se divulgan cambios en las operaciones, finanzas o transacciones adicionales.

Punto clave: Alafi sigue siendo un accionista pasivo con doble d铆gito, ofreciendo potencial influencia por poder pero sin mostrar intenci贸n activista.

Alafi Capital Company, LLC鞕� 攴� 甏�毽� 氅る矂 Christopher D. Alafi臧赌 CalciMedica, Inc. (CALC)鞐� 雽�頃� 13G 鞀れ紑欷� 靾橃爼鞎� 1順鸽ゼ 鞝滌稖頄堨姷雼堧嫟.

  • 靷贝 雮犾: 2025雲� 7鞗� 22鞚�; 鞝滌稖 雮犾: 2025雲� 8鞗� 5鞚�.
  • 鞁れ 靻岇湢 欤检嫕: 1,583,153 氤错喌欤�.
  • 鞝勳泊 氚滍枆 欤检嫕 13,971,990欤检潣 11.3%鞐� 頃措嫻頃� (2025雲� 5鞗� 14鞚检瀽 CALC 10-Q 旮办).
  • 氇摖 欤检嫕鞚� Alafi Capital鞚� 氤挫湢; Alafi 鞌姅 雼弲 甏�毽� 氅る矂搿滌劀 雼弲 鞚橁舶甓� 氚� 觳橂秳 甓岉暅鞚� 臧赌歆�.
  • 瓿奠湢 甓岉暅 鞐嗢潓; 鞚� 歆�攵勳潃 Rule 13d-1(c)鞐� 霐半澕 靾橂彊鞝� 韴瀽搿� 鞁犼碃霅�.

鞚胳靹滊姅 頃措嫻 歃濌秾鞚� 氚滍枆靷� 歆�氚瓣秾鞐� 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲媹氅�, 攴鸽９ 霕愲姅 鞛愴殞靷� 甏�瓿勱岸� 鞐嗢潓鞚� 氇呾嫓頃╇媹雼�. 須岇偓 鞖挫榿, 鞛 霕愲姅 於旉岸� 瓯半灅鞐� 雽�頃� 氤�瓴� 靷暛鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

頃奠嫭 鞖旍爯: Alafi電� 霊� 鞛愲靾橃潣 靾橂彊鞝� 氤挫湢鞛愲 雮晞 鞛堨溂氅�, 鞛犾灛鞝� 雽�毽� 鞓來枼霠レ潉 鞝滉车頃橃毵� 頄夒彊欤检潣 鞚橂弰電� 鞐嗢潓鞚� 鞁滌偓頃╇媹雼�.

Alafi Capital Company, LLC et son membre gestionnaire Christopher D. Alafi ont d茅pos茅 l'Amendement n掳1 au Schedule 13G pour CalciMedica, Inc. (CALC).

  • Date de l'茅v茅nement : 22 juillet 2025 ; date de d茅p么t : 5 ao没t 2025.
  • Participation b茅n茅ficiaire : 1 583 153 actions ordinaires.
  • 搁别辫谤茅蝉别苍迟别 11,3 % des 13 971 990 actions en circulation (selon le 10-Q de CALC en date du 14 mai 2025).
  • Toutes les actions sont d茅tenues par Alafi Capital ; M. Alafi, en tant que membre gestionnaire unique, d茅tient le pouvoir exclusif de vote et de disposition.
  • Pas de pouvoir partag茅 ; la participation est d茅clar茅e selon la r猫gle 13d-1(c) comme un investissement passif.

La certification pr茅cise que les titres n'ont pas 茅t茅 acquis dans le but d'influencer le contr么le de l'茅metteur et qu'aucune relation de groupe ou filiale ne s'applique. Aucun changement dans les op茅rations, les finances ou des transactions suppl茅mentaires n'est divulgu茅.

Point cl茅 : Alafi reste un actionnaire passif 脿 deux chiffres, offrant une influence potentielle par procuration mais sans intention activiste.

Alafi Capital Company, LLC und sein gesch盲ftsf眉hrendes Mitglied Christopher D. Alafi haben die 脛nderung Nr. 1 zum Schedule 13G f眉r CalciMedica, Inc. (CALC) eingereicht.

  • Veranstaltungsdatum: 22. Juli 2025; Einreichungsdatum: 5. August 2025.
  • Beg眉nstigter Eigentum: 1.583.153 Stammaktien.
  • Entspricht 11,3 % von 13.971.990 ausstehenden Aktien (laut CALC 10-Q vom 14. Mai 2025).
  • Alle Aktien werden von Alafi Capital gehalten; Herr Alafi besitzt als alleiniger gesch盲ftsf眉hrender Gesellschafter alleinige Stimm- und Verf眉gungsgewalt.
  • Keine geteilte Macht; Beteiligung wird gem盲脽 Regel 13d-1(c) als passive Investition gemeldet.

Die Bescheinigung besagt, dass die Wertpapiere nicht zum Zweck der Kontrolle des Emittenten erworben wurden und keine Gruppen- oder Tochtergesellschaftsbeziehungen vorliegen. Es werden keine 脛nderungen an der Gesch盲ftst盲tigkeit, den Finanzen oder weiteren Transaktionen offengelegt.

Wichtigste Erkenntnis: Alafi bleibt ein passiver Anteilseigner mit zweistelligem Anteil, der potenziellen Einfluss 眉ber Stimmrechtsvertretung bietet, aber keine aktivistischen Absichten signalisiert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KIM JAMES J
(Last) (First) (Middle)
C/O SIANA CARR O'CONNOR & LYNAM
1500 EAST LANCASTER AVENUE
(Street)
PAOLI PA 19301-9713
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMKOR TECHNOLOGY, INC. [ AMKR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) X Other (specify below)
Member of 10% owner group (4)
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 S 441,589(1) D $21.85 2,341,239 D
Common Stock 7,828,682(2)(3) I By John T. Kim Family Trust U/A dtd. 12/11/12
Common Stock 1,957,350(2)(3) I By John T. Kim G-S Trust dtd. 12/11/12
Common Stock 1,833,000(2)(3) I By Spouse
Common Stock 164,678(2)(3) I By self as Trustee of Trust U/A dtd. 12/11/12
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On August 1, 2025, the Reporting Person distributed 441,589 shares of the Common Stock of Amkor Technology, Inc. (the "Issuer") to Sujoda Investments, LP pursuant to the terms of a transaction between members of the Kim family group.
2. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities, except to the extent of the Reporting Person's pecuniary interest therein, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or for any other purpose.
3. The Reporting Person is (i) a trustee of trusts for the benefit of his immediate family members which own 9,786,032 shares of the Issuer's Common Stock and (ii) a trustee of a trust which is a controlling member of a limited liability company being treated as a corporation for purposes of Section 16, which limited liability company holds 164,678 shares of the Issuer's Common stock. Pursuant to the Form 4 instructions, the Reporting Person is being treated as having a pecuniary interest in all of such shares.
Remarks:
(4) The Reporting Person states that the filing of this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities owned by the other members of the group, for the purpose of Section 16, or for any other purpose.
/s/ Brian D. Short, Attorney-in-Fact for James J. Kim 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

Stock AMKR logo
Amkor Tech

NASDAQ:AMKR

AMKR Rankings

#1808 Ranked by Market Cap
#1633 Ranked by Dividends

AMKR Latest News

Jul 28, 2025
Amkor Technology Reports Financial Results for the Second Quarter 2025
Jul 7, 2025
Amkor Technology to Announce Second Quarter 2025 Financial Results on July 28, 2025
May 15, 2025
Amkor Technology Declares Quarterly Dividend
Apr 29, 2025
Amkor Technology to Present at the J.P. Morgan Global Technology, Media and Communications Conference
Apr 28, 2025
Amkor Technology Reports Financial Results for the First Quarter 2025

AMKR Latest SEC Filings

Aug 5, 2025
[Form 4] Amkor Technology Inc Insider Trading Activity
Aug 5, 2025
[Form 4] Amkor Technology Inc Insider Trading Activity
Aug 5, 2025
[Form 4] Amkor Technology Inc Insider Trading Activity
Aug 5, 2025
[Form 4] Amkor Technology Inc Insider Trading Activity
Aug 5, 2025
[Form 4] Amkor Technology Inc Insider Trading Activity

AMKR Stock Data

5.48B
113.80M
53.95%
45.37%
2.56%
Semiconductor Equipment & Materials
Semiconductors & Related Devices
United States
TEMPE